Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Vokinger, K. N. et al. Analysis of launch and postapproval cancer drug pricing, clinical benefit, and policy implications in the US and Europe. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2021.2026 (2021).
2. OECD. Addressing challenges in access to oncology medicines. Analytical report. OECD https://www.oecd.org/health/health-systems/Addressing-Challenges-in-Access-to-Oncology-Medicines-Analytical-Report.pdf (2020).
3. IQVIA Institute. Global oncology trends 2021. IQVIA https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/global-oncology-trends-2021/global-oncology-trends-report-2021-05-21-forweb.pdf?_=1630425102649 (2021).
4. Will cancer drugs get cheaper in 2020? Nat. Rev. Clin. Oncol. 17, 127–127 (2020).
5. Bach, P. B. Indication-specific pricing for cancer drugs. JAMA 312, 1629 (2014).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献